# Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization

> **NCT05032391** · PHASE3 · COMPLETED · sponsor: **Limited Liability Company Pharm Aid** · enrollment: 100 (actual)

## Conditions studied

- Rotavirus Infection

## Interventions

- **BIOLOGICAL:** The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05032391
- **Lead sponsor:** Limited Liability Company Pharm Aid
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-22
- **Primary completion:** 2019-09-22
- **Final completion:** 2019-10-25
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05032391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05032391, "Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05032391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*